Scientific Advisory Board

Jerold Chun, M.D., Ph.D.

Chairman of Scientific Advisory Board

Dr. Chun is currently professor and the senior vice president of Neuroscience Drug Discovery at Sanford Burnham Prebys Medical Discovery Institute, with over 27 years of experience in academia and industry.  He currently leads a team of 25 researchers in the study of genomic mosaicism (DNA sequence variation in brain cells) and lysophospholipid receptor signaling to understand and develop drug treatments for brain diseases such as Alzheimer’s disease, multiple sclerosis, and hydrocephalus.  Dr. Chun previously held professorships at The Scripps Research Institute, the University of California San Diego School of Medicine, and also headed the Department of Molecular Neuroscience at Merck Research Laboratories.  Among his achievements, he identified the first lysophospholipid receptor (1996), was first to demonstrate genomic mosaicism in the brain (2001) and its alteration in Alzheimer’s disease (2015).  Dr. Chun is a recipient of over a dozen awards, has published ~300 scientific articles and three patents. He received M.D. and Ph.D. (Neuroscience) degrees through the Medical Scientist Training Program at Stanford University School of Medicine, and was a Helen Hay Whitney Fellow at the Whitehead Institute for Biomedical Research/MIT.

Stanley H. Appel, M.D.

Stanley H. Appel, M.D., is the Peggy and Gary Edwards Distinguished Endowed Professor for the Treatment and Research of ALS, Department of Neurology, Neurological Institute, Houston Methodist Hospital and Professor of Neurology at Weill Medical College of Cornell University. He is director of the MDA/ALS Research and Clinical Center at the Methodist Neurological Institute, and a past director of a National Institute of Aging Alzheimer’s Disease Research Center. He has received numerous awards for his accomplishments in neurology and biochemistry, including the Gold Medal Award in 1997 from Columbia College of Physicians and Surgeons for “Distinguished Achievements in Medicine” and the Sheila EsseyAward in 2003 from the American Academy of Neurology for “outstanding research in Amyotrophic Lateral Sclerosis.”

Amit Bar-Or, M.D.

Amit Bar-Or, M.D., a neurologist and neuroimmunologist, is the Presidential Endowed Chair at the University of Pennsylvania(UPenn/CHOP) and the Melissa and Paul Anderson Professor of Neurology, founder and director of the Centre for Neuroinflammation and Experimental Neurotherapeutics and chief, Multiple Sclerosis Division. He leads a cellular and molecular neuroimmunology lab that studies basic principles of immune regulation and immune­neural interaction, in the context of inflammation, injury and repair of the human central nervous system (CNS). He is President-Elect of the International Society of Neuroimmunology (ISNI) and serves on the board of directors of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and on the steering committee of the Immune Tolerance Network (ITN).